Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.00
Bid: 248.00
Ask: 248.60
Change: 3.00 (1.23%)
Spread: 0.60 (0.242%)
Open: 246.00
High: 250.60
Low: 244.80
Prev. Close: 244.00
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Man Group PLC : Form 8.3 - RWS Holdings plc

1 Oct 2020 12:07

Man Group PLC : Form 8.3 - RWS Holdings plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Man Group PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeRWS Holdings plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure30/09/2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/AIf YES, specify which: Offeree SDL PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:    
(2) Cash-settled derivatives:   - 269,412 -0.0979
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:   - 0
TOTAL:  - 269,412 -0.0979

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
1p ordinaryCFDIncreasing a short position8,8215.6200
1p ordinaryCFDDecreasing a short position8,8215.6200

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?YES/NO

Date of disclosure:01/10/2020
Contact name:Abdi Musse
Telephone number:+442071443164

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
26th Apr 20237:00 amRNSTrading Statement Q1 2023
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20236:00 pmRNSTransaction in Own Shares
29th Mar 20236:12 pmRNSTransaction in Own Shares
28th Mar 20235:50 pmRNSTransaction in Own Shares
28th Mar 20237:00 amRNSDirectorate Change
27th Mar 20235:48 pmRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTotal Voting Rights
24th Mar 20235:48 pmRNSTransaction in Own Shares
23rd Mar 20235:59 pmRNSTransaction in Own Shares
23rd Mar 202312:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:49 pmRNSTransaction in Own Shares
21st Mar 20235:38 pmRNSTransaction in Own Shares
20th Mar 20236:02 pmRNSTransaction in Own Shares
20th Mar 20235:00 pmRNSESEF Annual Report 2022
17th Mar 20236:04 pmRNSTransaction in Own Shares
16th Mar 20235:56 pmRNSTransaction in Own Shares
15th Mar 20235:50 pmRNSTransaction in Own Shares
14th Mar 20235:54 pmRNSTransaction in Own Shares
14th Mar 20231:05 pmRNSDirector/PDMR Shareholding
14th Mar 20231:00 pmRNSDirector/PDMR Shareholding
14th Mar 202310:00 amRNSAnnual Financial Report
13th Mar 20236:03 pmRNSTransaction in Own Shares
10th Mar 20235:48 pmRNSTransaction in Own Shares
9th Mar 20233:15 pmRNSShare buyback programme of up to $125million
9th Mar 202312:20 pmRNSTreasury Share Cancellation & Total Voting Rights
8th Mar 20235:54 pmRNSTransaction in Own Shares
8th Mar 202311:10 amRNSDirector/PDMR Shareholding
7th Mar 20236:00 pmRNSTransaction in Own Shares
6th Mar 20235:53 pmRNSTransaction in Own Shares
3rd Mar 20235:36 pmRNSTransaction in Own Shares
2nd Mar 20235:47 pmRNSTransaction in Own Shares
1st Mar 20235:54 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
28th Feb 20235:44 pmRNSTransaction in Own Shares
28th Feb 20237:01 amRNSDirectorate Change
28th Feb 20237:00 amRNSFinancial results for the year ended 31 Dec 2022
27th Feb 20235:47 pmRNSTransaction in Own Shares
24th Feb 20235:35 pmRNSTransaction in Own Shares
23rd Feb 20235:49 pmRNSTransaction in Own Shares
22nd Feb 20236:03 pmRNSTransaction in Own Shares
21st Feb 20235:49 pmRNSTransaction in Own Shares
20th Feb 20235:55 pmRNSTransaction in Own Shares
17th Feb 20235:50 pmRNSTransaction in Own Shares
16th Feb 20235:43 pmRNSTransaction in Own Shares
15th Feb 20235:54 pmRNSTransaction in Own Shares
14th Feb 20236:31 pmRNSTransaction in Own Shares
13th Feb 20235:26 pmRNSTransaction in Own Shares
10th Feb 20235:52 pmRNSTransaction in Own Shares
9th Feb 20235:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.